packageFirmonertinib

firmonertinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Firmonertinib is an investigational EGFR tyrosine kinase inhibitor being studied as an anticancer treatment. It is not yet approved; it remains in clinical development and is not authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q140641519 and the WHO ATC classification; not checked by a person.

name:firmonertinib
ATC codes:L01EB12
DrugBank:DB16087
PubChem CID:118861389
Wikidata:Q140641519
formula:C28H31F3N8O2
molar mass:568.604 g/mol (PubChem CID 118861389)

Metabolites

AST5902AST5902554.577 g/mol (pubchem)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
AST5902metabolite: AST5902